BioLASCO Taiwan Market Cap

BioLASCO Taiwan has a market cap or net worth of 751.71 million as of March 9, 2026. Its market cap has decreased by -16.14% in one year.

Market Cap

751.71M

Enterprise Value

724.41M

Revenue

277.12M

Ranking

n/a

PE Ratio

16.80

Stock Price

29.65

Market Cap Chart

Since January 4, 2018, BioLASCO Taiwan's market cap has decreased from 1.58B to 751.71M, a decrease of -52.45%. That is a compound annual growth rate of -8.69%.

Market Cap History

Date	Market Cap	% Change
Mar 9, 2026	751.71M	-5.32%
Dec 31, 2025	793.97M	-6.34%
Dec 31, 2024	847.76M	-0.30%
Dec 29, 2023	850.32M	11.22%
Dec 30, 2022	764.52M	-1.97%
Dec 30, 2021	779.89M	-13.74%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SynCore Biotechnology Co.,Ltd	715.61M
Eusol Biotech	863.10M
Neith	899.73M
TaiwanJ Pharmaceuticals	616.94M
NatureWise Biotech & Medicals	940.05M
TCI GENE	949.86M
Taiwan Advance Bio-Pharmaceutical	958.50M
Vectorite Biomedical	588.72M

Market Cap Rankings